Aesica Queenborough is an API and finished-dose manufacturer based in United Kingdom. It holds one active US drug master file. Its filings concentrate with MINSA (CR), NAFDAC (NG) and DIGEMAPS (DO). Its GMP standing is certified by MFDS (Korea), NAFDAC (NG) and ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| QUEENBOROUGH, United Kingdom | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Isoflurane | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 6 | None |
| NAFDAC (NG) | 2 | 1 |
| DIGEMAPS (DO) | 2 | None |
| FDA (GH) | 1 | None |
| NPRA (MY) | 1 | None |
| MFDS (Korea) | None | 2 |
| ANVISA (Brazil) | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Aesica Queenborough comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.